Insider Transactions Reported by 19 Insiders of Opus Genetics, Inc.

Symbol
IRD on Nasdaq
Location
Durham, NC

Insiders trading volume in the past year

Opus Genetics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Foundation Fighting Blindness Retinal Degeneration Fund Director, Other* $11.8M -$8.6M -42.1% 09 Dec 2025
George Magrath Chief Executive Officer, Director $2.97M 01 Nov 2025
Cam Gallagher Director $2.08M 25 Aug 2025
BENJAMIN R. YERXA President, Director $622K 22 Oct 2025
Jay Pepose Director $319K 11 Jun 2024
Ronil A. Patel Chief Business Officer $296K 10 Jan 2024
Sean Ainsworth Director $293K 25 Aug 2025
Richard J. Rodgers Director $284K 30 Apr 2025
S. MANUSO JAMES Director $233K 30 Apr 2025
Nirav S. Jhaveri Chief Financial Officer $223K 13 Mar 2025
Bernhard Hoffmann SVP of Corp. Dev. $213K 13 Mar 2025
Robert E. Gagnon Chief Financial Officer $212K 02 Sep 2025
Susan Benton Director $195K 30 Apr 2025
Jean Bennett Director $190K 30 Apr 2025
Mina Sooch President and CEO, Director $163K 10 Jan 2023
Ashwath Jayagopal Chief Scientific & Dev. Ofc. $145K 13 Mar 2025
Rabourn Amy Zaremba SVP of Finance $131K 13 Mar 2025
Adrienne L. Graves Director $70.8K 30 Apr 2025
JOSEPH K. SCHACHLE Chief Operating Officer $62.7K 13 Mar 2025

Recent Insider Transactions by Companies or Individuals for Opus Genetics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.